Article
Expression of Neuroendocrine Factor VGF in Lung Cancer Cells Confers Resistance to EGFR Kinase Inhibitors and Triggers Epithelial-to-Mesenchymal Transition.
Cancer research - 1 Jun 2017
Hwang Wen, Chiu Yu-Fan, Kuo Ming-Han, Lee Kuan-Lin, Lee An-Chun, Yu Chia-Cherng, Chang Junn-Liang, Huang Wen-Chien, Hsiao Shih-Hsin, Lin Sey-En, Chou Yu-Ting
Abstract excerpt
Mutations in EGFR drive tumor growth but render tumor cells sensitive to treatment with EGFR tyrosine kinase inhibitors (TKI). Phenotypic alteration in epithelial-to-mesenchymal transition (EMT) has been linked to the TKI resistance in lung adenocarcinoma. However, the mechanism underlying this resistance remains unclear. Here we report that high expression of a neuroendocrine factor termed VGF induces the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
